{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:05:22Z","timestamp":1790798722452,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacadv.2026.103220","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:51:42Z","timestamp":1790797902000},"page":"103220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prioritizing Selective Use of Apolipoprotein-B Testing in the Era of Modern LDL-Cholesterol Calculation"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-0876","authenticated-orcid":false,"given":"Alexander C.","family":"Razavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9071-3287","authenticated-orcid":false,"given":"Michael D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-7435","authenticated-orcid":false,"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7720-7470","authenticated-orcid":false,"given":"Eugenia","family":"Gianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.103220_bib1","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.103220_bib2","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of dyslipidemia: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103220_bib3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.103220_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2026.2314","article-title":"Development and validation of a simplified Martin-Hopkins LDL-C equation using machine learning","author":"Park","year":"2026","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.103220_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCULATIONAHA.125.077998","article-title":"Prevalence of apolipoprotein B and LDL cholesterol discordance: insights from the VLDbL and NHANES","volume":"153","author":"Peng","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103220_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCULATIONAHA.117.032463","article-title":"Impact of novel low-density lipoprotein-cholesterol assessment on the utility of secondary non-high-density Lipoprotein-C and apolipoprotein B targets in selected Worldwide Dyslipidemia Guidelines","volume":"138","author":"Sathiyakumar","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103220_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamacardio.2024.1310","article-title":"Individual variation in the distribution of apolipoprotein B levels across the spectrum of LDL-C or Non-HDL-C levels","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.103220_bib8","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103220_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.2026.2986","article-title":"Cost-effectiveness of ApoB, Non-HDL-C, and LDL-C goals for primary prevention lipid-lowering therapy","volume":"335","author":"Luebbe","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.103220_bib10","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehaf1124","article-title":"Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease","volume":"47","author":"Rehman","year":"2026","journal-title":"Eur Heart J"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:51:43Z","timestamp":1790797903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26006411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"alternative-id":["S2772963X26006411"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103220","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritizing Selective Use of Apolipoprotein-B Testing in the Era of Modern LDL-Cholesterol Calculation","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103220"}}